Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Amortization of Deferred Charges (2022 - 2026)

HeartSciences filings provide 4 years of Amortization of Deferred Charges readings, the most recent being $21287.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 80.64% to $21287.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $505067.0, a 286.52% increase, with the full-year FY2025 number at $285870.0, up 175.95% from a year prior.
  • Amortization of Deferred Charges hit $21287.0 in Q1 2026 for HeartSciences, down from $263880.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $263880.0 in Q4 2025 to a low of $20719.0 in Q1 2024.
  • Median Amortization of Deferred Charges over the past 4 years was $109950.0 (2025), compared with a mean of $102485.2.
  • Biggest five-year swings in Amortization of Deferred Charges: skyrocketed 430.67% in 2025 and later plummeted 80.64% in 2026.
  • HeartSciences' Amortization of Deferred Charges stood at $61381.0 in 2022, then tumbled by 66.25% to $20719.0 in 2024, then soared by 1173.61% to $263880.0 in 2025, then tumbled by 91.93% to $21287.0 in 2026.
  • The last three reported values for Amortization of Deferred Charges were $21287.0 (Q1 2026), $263880.0 (Q4 2025), and $109950.0 (Q3 2025) per Business Quant data.